Ignite Creation Date:
2024-05-11 @ 8:31 AM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06406972
Status:
RECRUITING
Last Update Posted:
2024-05-09
First Post:
2024-04-19
Brief Title:
Brief Admission by Self-referral for Individuals With Self-harm Effects on Compulsory Care
Sponsor:
Region Skane
Organization:
Region Skane
Study Overview
Official Title:
Brief Admission by Self-referral for Individuals With Self-harm Effects on Compulsory Care
Status:
RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Brief Admission by self-referral BA is a standardized treatment model providing patient-controlled and person-centered care It was developed to reduce self-harm and compulsory care by promoting autonomy Randomized clinical trials have not yielded significant between group differences with respect to inpatient care including compulsory care The major difficulty in evaluating BA is preventing the control group from cross-contamination as in the implementation process of BA all physicians all inpatient and outpatient staff as well as managers need to be informed and undergo basic education regarding the intervention As BA addresses a prevalent and frustrating issue in psychiatric health care there is considerable risk that the approach leaks to the control group reducing the possibility to detect between-group differences In the current study this will be addressed through a register-based approach comparing similar clinics implementing BA at different timepoints over time Individuals with traits of borderline personality disorder will be included and comparisons will be made with respect to compulsory care voluntary inpatient care and mortality
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None